An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).

Adenosine deaminase acting on RNA1 (ADAR1) catalyzes the C6 deamination of adenosine (A) to produce inosine (I) in regions of RNA with double-stranded (ds) character. This process is known as A-to-I RNA editing. Alternative promoters drive the expression of the Adar1 gene and alternative splicing gives rise to transcripts that encode 2 ADAR1 protein size isoforms. ADAR1 p150 is an interferon (IFN)-inducible dsRNA adenosine deaminase found in the cytoplasm and nucleus, whereas ADAR1 p110 is constitutively expressed and nuclear in localization. Dependent on the duplex structure of the dsRNA substrate, deamination of adenosine by ADAR can be either highly site-selective or nonspecific. A-to-I editing can alter the stability of RNA structures and the coding of RNA as I is read as G instead of A by ribosomes during mRNA translation and by polymerases during RNA replication. A-to-I editing is of broad physiologic significance. Both the production and the action of IFNs, and hence the subsequent interaction of viruses with their hosts, are among the processes affected by A-to-I editing.

[1]  Charles M. Rice,et al.  Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.

[2]  M. Kimura,et al.  Enhancement of alcohol drinking in mice depends on alterations in RNA editing of serotonin 2C receptors. , 2014, The international journal of neuropsychopharmacology.

[3]  S. Orcesi,et al.  Bilateral striatal necrosis in two subjects with Aicardi–Goutières syndrome due to mutations in ADAR1 (AGS6) , 2014, American journal of medical genetics. Part A.

[4]  Yan Li,et al.  Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. , 2014, Cancer research.

[5]  K. Nishikura,et al.  Adenosine-to-inosine RNA editing and human disease , 2013, Genome Medicine.

[6]  A. Munnich,et al.  A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1 , 2013, Journal of Medical Genetics.

[7]  Ashley M. Jacobi,et al.  Inosine-Mediated Modulation of RNA Sensing by Toll-Like Receptor 7 (TLR7) and TLR8 , 2013, Journal of Virology.

[8]  Yanhong Tai,et al.  ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding , 2013, RNA.

[9]  M. Radeke,et al.  Measles Virus C Protein Impairs Production of Defective Copyback Double-Stranded Viral RNA and Activation of Protein Kinase R , 2013, Journal of Virology.

[10]  N. Amariglio,et al.  F11R Expression upon Hypoxia Is Regulated by RNA Editing , 2013, PloS one.

[11]  Kol Jia Yong,et al.  A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma , 2013, Gut.

[12]  Aamira Tariq,et al.  A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing , 2013, RNA biology.

[13]  T. Shimokawa,et al.  RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling , 2013, RNA biology.

[14]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[15]  Jessica M. Rusert,et al.  ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia , 2012, Proceedings of the National Academy of Sciences.

[16]  B. Ang,et al.  Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. , 2012, The Journal of clinical investigation.

[17]  C. Samuel,et al.  Stress Granule Formation Induced by Measles Virus Is Protein Kinase PKR Dependent and Impaired by RNA Adenosine Deaminase ADAR1 , 2012, Journal of Virology.

[18]  John H Livingston,et al.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.

[19]  Nora Taghavi,et al.  Protein Kinase PKR Amplification of Interferon β Induction Occurs through Initiation Factor eIF-2α-mediated Translational Control* , 2012, The Journal of Biological Chemistry.

[20]  K. Rohr,et al.  Dynamic oscillation of translation and stress granule formation mark the cellular response to virus infection. , 2012, Cell host & microbe.

[21]  Angela Gallo,et al.  A-to-I RNA editing: the "ADAR" side of human cancer. , 2012, Seminars in cell & developmental biology.

[22]  R. Emeson,et al.  Quantitative analysis of 5HT2C receptor RNA editing patterns in psychiatric disorders , 2012, Neurobiology of Disease.

[23]  C. Samuel,et al.  Adenosine Deaminase Acting on RNA 1 (ADAR1) Suppresses the Induction of Interferon by Measles Virus , 2012, Journal of Virology.

[24]  Phalguni Gupta,et al.  ADAR1 is a novel multi targeted anti-HIV-1 cellular protein. , 2012, Virology.

[25]  C. Samuel,et al.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. , 2011, Current opinion in immunology.

[26]  M. Gale,et al.  RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity , 2011, Current Opinion in Virology.

[27]  Anne Gatignol,et al.  Enhancement of Replication of RNA Viruses by ADAR1 via RNA Editing and Inhibition of RNA-Activated Protein Kinase , 2011, Journal of Virology.

[28]  S. Levine,et al.  Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. , 2011, Cytokine & growth factor reviews.

[29]  C. Samuel,et al.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. , 2011, Virology.

[30]  A. Sadler,et al.  The role of protein kinase R in the interferon response. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[31]  Yong Liu,et al.  Adenosine deaminases acting on RNA, RNA editing, and interferon action. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[32]  C. Samuel,et al.  RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis , 2010, Proceedings of the National Academy of Sciences.

[33]  J. Meador-Woodruff,et al.  Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims , 2010, Neuroreport.

[34]  E. Nevo,et al.  Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates , 2010, Proceedings of the National Academy of Sciences.

[35]  K. Nishikura Functions and regulation of RNA editing by ADAR deaminases. , 2010, Annual review of biochemistry.

[36]  S. Akira,et al.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors , 2010, Nature Immunology.

[37]  C. Samuel,et al.  RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. , 2010, Virology.

[38]  M. Yoneyama,et al.  Recognition of viral nucleic acids in innate immunity , 2010, Reviews in medical virology.

[39]  C. Samuel,et al.  Mechanisms of Protein Kinase PKR-Mediated Amplification of Beta Interferon Induction by C Protein-Deficient Measles Virus , 2009, Journal of Virology.

[40]  T. Cheng,et al.  ADAR1 is required for hematopoietic progenitor cell survival via RNA editing , 2009, Proceedings of the National Academy of Sciences.

[41]  R. Cattaneo,et al.  RNA-specific Adenosine Deaminase ADAR1 Suppresses Measles Virus-induced Apoptosis and Activation of Protein Kinase PKR* , 2009, The Journal of Biological Chemistry.

[42]  A. Gallo,et al.  Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection , 2009, Nucleic acids research.

[43]  E. Meurs,et al.  ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication , 2009, Journal of Virology.

[44]  William M. Lee,et al.  Variants in interferon‐alpha pathway genes and response to pegylated interferon‐Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long‐term treatment against cirrhosis trial , 2009, Hepatology.

[45]  Y. Hurd,et al.  Editing of Serotonin 2C Receptor mRNA in the Prefrontal Cortex Characterizes High Novelty Locomotor Response Behavioral Trait , 2009, Neuropsychopharmacology.

[46]  S. Orkin,et al.  ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling , 2008, Nature Immunology.

[47]  C. Samuel,et al.  Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5'-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. , 2008, Virology.

[48]  P. Auewarakul,et al.  Double-Stranded RNA Adenosine Deaminases Enhance Expression of Human Immunodeficiency Virus Type 1 Proteins , 2008, Journal of Virology.

[49]  Jochen C. Hartner,et al.  Specificity of ADAR-mediated RNA editing in newly identified targets. , 2008, RNA.

[50]  Graham R. Foster,et al.  Interferons at age 50: past, current and future impact on biomedicine , 2007, Nature Reviews Drug Discovery.

[51]  A. Rich,et al.  A Left-Handed RNA Double Helix Bound by the Zα Domain of the RNA-Editing Enzyme ADAR1 , 2007 .

[52]  Y. Nie,et al.  Double-Stranded RNA Deaminase ADAR1 Increases Host Susceptibility to Virus Infection , 2006, Journal of Virology.

[53]  C. Samuel,et al.  Expression of Interferon-inducible RNA Adenosine Deaminase ADAR1 during Pathogen Infection and Mouse Embryo Development Involves Tissue-selective Promoter Utilization and Alternative Splicing* , 2005, Journal of Biological Chemistry.

[54]  Alexander Rich,et al.  Widespread A-to-I RNA Editing of Alu-Containing mRNAs in the Human Transcriptome , 2004, PLoS biology.

[55]  T. Matise,et al.  Widespread RNA editing of embedded alu elements in the human transcriptome. , 2004, Genome research.

[56]  Zipora Y. Fligelman,et al.  Systematic identification of abundant A-to-I editing sites in the human transcriptome , 2004, Nature Biotechnology.

[57]  T. Dawson,et al.  Structure and Sequence Determinants Required for the RNA Editing of ADAR2 Substrates* , 2004, Journal of Biological Chemistry.

[58]  P. Seeburg,et al.  Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1* , 2004, Journal of Biological Chemistry.

[59]  M. Weiss,et al.  Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene* , 2004, Journal of Biological Chemistry.

[60]  I. Greger,et al.  AMPA Receptor Tetramerization Is Mediated by Q/R Editing , 2003, Neuron.

[61]  P. Seeburg,et al.  Regulation of ion channel/neurotransmitter receptor function by RNA editing , 2003, Current Opinion in Neurobiology.

[62]  A. Rich,et al.  A role for Z-DNA binding in vaccinia virus pathogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Victoria Arango,et al.  Altered Editing of Serotonin 2C Receptor Pre-mRNA in the Prefrontal Cortex of Depressed Suicide Victims , 2002, Neuron.

[64]  J. Kjems,et al.  CRM1 Mediates the Export of ADAR1 through a Nuclear Export Signal within the Z-DNA Binding Domain , 2001, Molecular and Cellular Biology.

[65]  Colleen M Niswender,et al.  RNA Editing of the Human Serotonin 5-HT2C Receptor: Alterations in Suicide and Implications for Serotonergic Pharmacotherapy , 2001, Neuropsychopharmacology.

[66]  C. Samuel,et al.  Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. , 2000, Gene.

[67]  C. Samuel,et al.  Assignment1 of the RNA-specific adenosine deaminase gene (Adar) to mouse chromosome 3F2 by in situ hybridization , 2000, Cytogenetic and Genome Research.

[68]  M. Mathews,et al.  Proteins binding to duplexed RNA: one motif, multiple functions. , 2000, Trends in biochemical sciences.

[69]  K. Nishikura,et al.  Altered G Protein‐Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin2C Receptors , 2000, Journal of neurochemistry.

[70]  D. Menkes,et al.  Interferons, serotonin and neurotoxicity , 2000, Psychological Medicine.

[71]  K. A. Lehmann,et al.  The importance of internal loops within RNA substrates of ADAR1. , 1999, Journal of molecular biology.

[72]  P. Hartig,et al.  Messenger RNA Editing of the Human Serotonin 5-HT2C Receptor , 1999, Neuropsychopharmacology.

[73]  R. Emeson,et al.  Serotonin-2C Receptor Pre-mRNA Editing in Rat Brain andin Vitro by Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1* , 1999, The Journal of Biological Chemistry.

[74]  A. Rich,et al.  Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. , 1999, Science.

[75]  C. Samuel,et al.  Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Colleen M. Niswender,et al.  RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity* , 1999, The Journal of Biological Chemistry.

[77]  C. Samuel,et al.  Characterization of the 5'-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. , 1999, Gene.

[78]  Yong Liu,et al.  Editing of Glutamate Receptor Subunit B Pre-mRNA by Splice-site Variants of Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase ADAR1* , 1999, The Journal of Biological Chemistry.

[79]  P. Seeburg,et al.  A standardized nomenclature for adenosine deaminases that act on RNA. , 1997, RNA.

[80]  I. Mian,et al.  A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[81]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[82]  M. Kasuga,et al.  Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes* , 1997, The Journal of Biological Chemistry.

[83]  Yong Liu,et al.  Functionally Distinct Double-stranded RNA-binding Domains Associated with Alternative Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase* , 1997, The Journal of Biological Chemistry.

[84]  C. Samuel,et al.  Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase , 1996, Journal of virology.

[85]  J. Casey,et al.  Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA , 1995, Journal of virology.

[86]  K. Nishikura,et al.  Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. , 1995, Journal of molecular biology.

[87]  C. Samuel,et al.  The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. , 1995, Genomics.

[88]  C. Samuel,et al.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.

[89]  C. Samuel,et al.  Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. , 1995, Virology.

[90]  M. Higuchi,et al.  Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase , 1995, Molecular and cellular biology.

[91]  T Kuner,et al.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. , 1994, Science.

[92]  K. Nishikura,et al.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[93]  P. Seeburg,et al.  RNA editing of AMPA receptor subunit GluR-B: A base-paired intron-exon structure determines position and efficiency , 1993, Cell.

[94]  J. Casey,et al.  Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[95]  B. Sakmann,et al.  Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit , 1992, Neuron.

[96]  P. Seeburg,et al.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels , 1991, Cell.

[97]  J. E. Smith,et al.  A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[98]  Brenda L. Bass,et al.  An unwinding activity that covalently modifies its double-stranded RNA substrate , 1988, Cell.

[99]  Roberto Cattaneo,et al.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.

[100]  V. Tăriceanu [The interferon system]. , 1987, Viata medicala; revista de informare profesionala si stiintifica a cadrelor medii sanitare.

[101]  P. I. Marcus,et al.  Defective interfering particles with covalently linked [±]RNA induce interferon , 1977, Nature.

[102]  M. Hilleman,et al.  Inducers of Interferon and Host Resistance VII. Antiviral Efficacy of Double-Stranded RNA of Natural Origin , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[103]  M. Hilleman,et al.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[104]  The Left-Handed * , 1919 .

[105]  A. Serretti,et al.  Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials. , 2014, The international journal of neuropsychopharmacology.

[106]  R. Emeson,et al.  Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. , 2012, Current topics in microbiology and immunology.

[107]  J. Casey Control of ADAR1 editing of hepatitis delta virus RNAs. , 2012, Current Topics in Microbiology and Immunology.

[108]  S. Maas Posttranscriptional recoding by RNA editing. , 2012, Advances in protein chemistry and structural biology.

[109]  M. Oldstone Modeling subacute sclerosing panencephalitis in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. , 2009, Current topics in microbiology and immunology.

[110]  R. Emeson,et al.  RNA editing as a therapeutic target for CNS disorders , 2009, Neuropsychopharmacology.

[111]  S. Goodbourn,et al.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.

[112]  A. Rich,et al.  A left-handed RNA double helix bound by the Z alpha domain of the RNA-editing enzyme ADAR1. , 2007, Structure.

[113]  C. Samuel,et al.  Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. , 2006, Progress in nucleic acid research and molecular biology.

[114]  B. Bass,et al.  Adar Editing in Double-stranded Utrs and Other Noncoding Rna Sequences , 2022 .

[115]  Jin Billy Li,et al.  Edinburgh Research Explorer Identifying Rna Editing Sites Using Rna Sequencing Data Alone , 2022 .